Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q3 2017 Earnings

8AugConfirmed

Q4 2016

Q1 2017

Q2 2017

Q3 2017

-5.55

-4.85

-4.15

-3.45

Details

Expected EPS

-3.88

Actual EPS

-3.45

Surprise EPS

0.43

Surprise Percent

+11.08%

Description

Celldex Therapeutics (CLDX) has reported earnings of -3.45 per share for Q3 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.